期刊文献+

CXCR4启动子的克隆及在MCF-7乳腺癌细胞中的特异转录活性 被引量:1

Cloning of CXCR4 promoter and its specific transcriptional activity in MCF-7 breast cancer cell
下载PDF
导出
摘要 目的证实CXCR4启动子在乳腺癌细胞MCF-7中的特异转录活性。方法采用PCR方法扩增CXCR4启动子序列,将其分别克隆到含有报告基因增强绿色荧光蛋白(EGFP)的质粒载体pEGFP-1和含有Luciferase的质粒载体pGL3-Basic,经脂质体分别转染人正常乳腺上皮细胞系HBL-100和乳腺癌细胞MCF-7,荧光显微镜下观察EGFP的表达情况,同时测定两种细胞中荧光素酶表达的差异。结果CXCR4基因的启动子在肿瘤细胞中呈现高的转录活性;而在正常细胞中转录活性极低。结论CXCR4启动子在乳腺癌MCF-7细胞中具有很强的特异性,为进一步开发肿瘤的特异性基因治疗奠定了实验基础。 [Objective] To identgy the specific transcription of CXCR4 promoter in MCF-7 breast cancer ceils. [Methods] CXCR4 gene minimal promoter was PCR amplified anti cloned into the reporter plasrnid pEGFP-1 and pGL3-Basie. The constructs pEGFP/CXCR4 and pGL.3/CXCR4 were transfeeted into MCF-7 breast cancer cell and HBL-100 human epitheli',d cells respectively. The expression of EGFP and lueiferase were investigated respectively. [Results] 279 bp CXCR4 gene minimal promoter was obtained successfully by PCR from MCF-7 cell genomie DNA and pEGFP/CXC1R4 and pGL3/CXCR4 bearing CXCR4 gene promoter were constructed. At 20 hour post trans- feetion, the speeifie expression of the EGFP was detected in MCF-7 cell while litde expression of EGFP was in HBL-100 cell. In accordance with EGFP, lueiferase driven by CXCR4 also showed specific and high activity. [ Conclusion] The high transcriptional activity of CXCR4 gene promoter in MCF-7 cell indicates its potential utility as a novel candidate for transcriptional targeting of breast eancer.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第7期992-995,共4页 China Journal of Modern Medicine
基金 国家自然科学基金(No:30471962)
关键词 CXCR4 启动子 乳腺癌 特异转录活性 CXCR4 promoter breast cancer specific transcriptional activity
  • 相关文献

参考文献10

  • 1MULLER A, HOMEY B, SOTO H, et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001, 410: 50-56.
  • 2PAYNE AS, CORNELIUS LA. The role of ehemokines in melanoma tumor growth and metastasis [J]. Invest Dermatol, 2001, 18: 915-922.
  • 3MURAKAMI T. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells[J]. Cancer Res, 2002, 62: 7328-7334.
  • 4TAICHMAN RS, COOPER C, KELLER ET, et al. Use of the stromal cell-derived factor-1/ CXCR4 pathway in prostate cancer metastasis to bone[J]. Cancer Res, 2002, 62: 1832-1837.
  • 5王宝利,梁晖,戴芳,郭刚,张镜宇.重叠延伸PCR法在合成人骨保护素N端编码序列中的应用[J].天津医科大学学报,2004,10(3):343-345. 被引量:15
  • 6SCHMID B, RUDAS M, RESNICZEK G, et al. CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia [J]. Breast Cancer Res. Treat, 2004, 84: 247-250.
  • 7HELBIG G, CHRISTOPHERSON KW, BHAT-NAKSHATRI P, et al. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CX- CR4[J]. J Biol Chem, 2003, 278: 21631-21638.
  • 8STALLER P, SULITKOVA J, LISZTWAN J, et al. Chemokine receptor CXCR4 downregulated by yon Hippel-Lindau turnout suppressor pVHL[J]. Nature, 2003, 425: 307-311.
  • 9WEGNER SA, EHRENBERG PK, CHANG G, et al. Genomie organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1[J]. J Biol Chem, 1998, 273: 4754-4760.
  • 10ZHU ZB, MAKHIJA SK, LU B, et al. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter [J]. Gene Ther, 2004, 11: 645-648.

二级参考文献7

  • 1Kostenuik PJ, Capparelli C, Morony S, et al. OPG and PTH - (1 - 34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats[J] . Endocrinology, 2001, 142(10) :4295
  • 2Schett G, Redlich K, Hayer S, et al. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor - transgenic mice[J ]. Arthritis Rheum, 2003, 48(7): 2042
  • 3Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin:a novel secreted protein involved in the regulation of bone densitv[J]. Cell, 1997, 89(2) :3095
  • 4Haynes DR, Barg E, Crotti TN, et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls[ J ]. Rheumatology, 2003, 42(1): 123
  • 5Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J ]. Cell, 1998, 93(2): 165
  • 6Nakashima T, Wada T, Penninger JM. RANKL and RANK as novel therapeutic targets for arthritis[J] . Curr Opin Rheumatol, 2003, 15(3):280
  • 7王宝利,郭若霖,左爱军,邱明才,张镜宇.破骨细胞分化因子和护骨素mRNA在OVX小鼠骨组织的相对表达[J].中华老年医学杂志,2003,22(10):608-611. 被引量:8

共引文献14

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部